Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066545 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
A Phase 2 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 327
- Enrollment target
NCT02066545 is a Phase 2 study that has completed, run by Maruho Co.. The registered enrollment target is 327 participants.
The verdict
NCT02066545, a Phase 2 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 327 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris
Interventions
- DRUG CLS001 Topical Gel
- DRUG CLS001 Topical Gel Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2014-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02066545
The ClinicalTrials.gov registry entry for NCT02066545 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho Co., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CLS001 Topical Gel is the first listed.
NCT02066545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02066545 about?
NCT02066545 is a clinical study titled "Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris". The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris
What is the current status of trial NCT02066545?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 327 participants. The study started on 2014-04.
What interventions are being tested in trial NCT02066545?
The interventions under investigation include: CLS001 Topical Gel (DRUG), CLS001 Topical Gel Vehicle (DRUG).
Who is sponsoring clinical trial NCT02066545?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.